Lidia Schapira, MD, Stanford, urges care teams to weigh quality of life, not just scans, in long-term cancer therapy decisions.
Lidia Schapira, MD, FASCO
Advertisement
Lidia Schapira, MD, FASCO, is a professor of medicine at Stanford Medicine, a medical oncologist, and director for both the Stanford Cancer Institute and the Stanford Comprehensive Cancer Center.
Articles by Lidia Schapira, MD, FASCO
Lidia Schapira, MD, FASCO, professor of medicine at Stanford Medicine, medical oncologist, and director for the Stanford Cancer Institute and the Stanford Comprehensive Cancer Center, shares ways in which clinicians can help enhance patient engagement and shared decision-making.
Lidia Schapira, MD, FASCO, professor of medicine at Stanford Medicine, medical oncologist, and director for the Stanford Cancer Institute and the Stanford Comprehensive Cancer Center, discusses the impact of social determinants of health (SDOH) when it comes to accessing innovative breast cancer treatments.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Novel Iberdomide Regimen in RRMM
2
Iberdomide Approval Elevates MRD’s Role in Myeloma: Prerna Mewawalla, MD
3
AI Model Outperforms Apnea-Hypopnea Index in Predicting Sleep Apnea Mortality Risk
4
Topical Delgocitinib Rivals Dupilumab for Hand Eczema, but Adherence Is Key
5